New hope for endometrial cancer: Rina-S takes on chemo in major trial

NCT ID NCT07166094

First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 26 times

Summary

This study tests a new drug called Rina-S against standard chemotherapy (paclitaxel or doxorubicin) in people with endometrial cancer that has come back or worsened after prior treatment. About 544 participants will be randomly assigned to receive either Rina-S or standard chemo. The goal is to see which treatment better delays cancer growth and extends survival. All participants receive an active drug; no one gets a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Institute Hospital of JFCR

    RECRUITING

    Tokyo, 135-8550, Japan

  • Emory Winship Cancer Inst.

    RECRUITING

    Atlanta, Georgia, 30308, United States

  • Emory Winship Cancer Inst.

    RECRUITING

    Atlanta, Georgia, 30322, United States

  • Emory Winship Cancer Inst./Emory Decatur Hospital

    RECRUITING

    Decatur, Georgia, 30033, United States

  • Fukushima Medical University Hospital

    RECRUITING

    Fukushima, 960-1247, Japan

  • Gunma Prefectural Cancer Center

    RECRUITING

    Ōta, Gunma, 373-8550, Japan

  • Hyogo Cancer Center

    RECRUITING

    Hyōgo, 673-0021, Japan

  • Iwate Medical University Hosp

    RECRUITING

    Shiwa-gun, Iwate, 028-3695, Japan

  • Kanagawa Cancer Center

    RECRUITING

    Yokohama, Kanagawa, 241-8515, Japan

  • Kitasato University Hospital

    RECRUITING

    Sagamihara-shi, Kanagawa, 252-0373, Japan

  • Mie University Hospital

    RECRUITING

    Tsu, Kansai, 514-8507, Japan

  • NEXT San Antonio

    RECRUITING

    San Antonio, Texas, 78240, United States

  • NUC Tohoku Univ. Hospital

    RECRUITING

    Sendai, Miyagi, 980-8574, Japan

  • NW Cancer Specs. P.C.

    RECRUITING

    Happy Valley, Oregon, 97015, United States

  • National Cancer Center Hospital East

    RECRUITING

    Chiba, 277-8577, Japan

  • National Hospital Organization Kyushu Cancer Center

    RECRUITING

    Fukuoka, 811-1347, Japan

  • Niigata Cancer Center Hospital

    RECRUITING

    Niigata, Japan

  • Osaka Medical and Pharmaceutical University Hospital

    RECRUITING

    Takatsuki, 569-8686, Japan

  • SMH - Sarasota - Main Campus

    RECRUITING

    Sarasota, Florida, 34239, United States

  • Saitama Medical University - International Medical Center

    RECRUITING

    Saitama, 350-1298, Japan

  • Sapporo Medical University Hospital

    RECRUITING

    Sapporo, 060-8543, Japan

  • Sinai Hospital

    RECRUITING

    Baltimore, Maryland, 21215, United States

  • TX Onc - Arlington North

    RECRUITING

    Arlington, Texas, 76012, United States

  • TX Onc - Bedford

    RECRUITING

    Bedford, Texas, 76022, United States

  • TX Onc - Methodist Charlton

    RECRUITING

    Dallas, Texas, 75237, United States

  • TX Onc - Methodist Dallas

    RECRUITING

    Dallas, Texas, 75203, United States

  • TX Onc - Presbyterian Dallas

    RECRUITING

    Dallas, Texas, 75231, United States

  • TX Onc - Sammons

    RECRUITING

    Dallas, Texas, 75246, United States

  • Trials365, LLC

    RECRUITING

    Shreveport, Louisiana, 71103, United States

  • USOR - Minnesota Oncology/ Coon Rapids Clinic

    RECRUITING

    Coon Rapids, Minnesota, 55433, United States

  • USOR - Minnesota Oncology/ Maple Grove Clinic

    RECRUITING

    Maple Grove, Minnesota, 55369, United States

  • USOR - Minnesota Oncology/ Maplewood Clinic

    RECRUITING

    Maplewood, Minnesota, 55109, United States

  • USOR - Minnesota Oncology/ Minneapolis Clinic

    RECRUITING

    Minneapolis, Minnesota, 55404, United States

  • USOR - Minnesota Oncology/ Woodbury Clinic

    RECRUITING

    Woodbury, Minnesota, 55125, United States

  • USOR - Minnesota Oncology/Edina Clinic

    RECRUITING

    Edina, Minnesota, 55435, United States

  • USOR - NW Cancer Specs P.C.

    RECRUITING

    Portland, Oregon, 97227, United States

  • USOR - NW Cancer Specs P.C.

    RECRUITING

    Vancouver, Washington, 98684, United States

  • USOR - NW Cancer Specs. P.C.

    RECRUITING

    Tigard, Oregon, 97223, United States

  • USOR - TX Oncology - SA NE

    RECRUITING

    San Antonio, Texas, 78217, United States

  • USOR - Texas Oncology

    RECRUITING

    Austin, Texas, 78731, United States

  • USOR - Texas Oncology

    RECRUITING

    Austin, Texas, 78745, United States

  • USOR - Texas Oncology

    RECRUITING

    Harlingen, Texas, 78550, United States

  • USOR - Texas Oncology

    RECRUITING

    McAllen, Texas, 78503, United States

  • USOR - Texas Oncology

    RECRUITING

    Weslaco, Texas, 78596, United States

  • USOR - Texas Oncology - Dallas Fort Worth (DFW)

    RECRUITING

    Fort Worth, Texas, 76104, United States

  • USOR - Texas Oncology- Austin North

    RECRUITING

    Austin, Texas, 78758, United States

  • USOR - Texas Oncology- Horizon Circle

    RECRUITING

    Waco, Texas, 76712, United States

  • USOR - Texas Oncology- Waco

    RECRUITING

    Waco, Texas, 76712, United States

  • Willamette Valley Cancer Institute and Research Center - Eugene

    RECRUITING

    Eugene, Oregon, 97401, United States

  • William Kahlert Reg. Can. Ctr

    RECRUITING

    Westminster, Maryland, 21157, United States

  • Yamagata University Hospital

    RECRUITING

    Yamagata, 990-9585, Japan

Conditions

Explore the condition pages connected to this study.